PRESS RELEASE: Leading Health Experts Send Letter to Congress Urging the PASTEUR Act’s Exclusion From NDAA
PRESS RELEASE: Doctors for America’s FDA Task Force Meets Legislators for a Third Time Ahead of End of Year Package
PRESS RELEASE: Doctors For America’s FDA Task Force is Deeply Concerned that the FDA Failed to Prioritize Patient Safety in Recent Alzheimer’s Drug Approval
PRESS RELEASE: Doctors for America’s FDA Task Force Files Amicus Brief to Protect Patients’ Access to Medication Abortion
PRESS RELEASE: Doctors for America’s FDA Task Force Meets with Legislators Ahead of the FDA Advisory Committee Meeting on the Peripheral and Central Nervous System Drugs
STATEMENT RELEASE: Doctors For America’s FDA Task Force’s Statement on the FDA’s Decision to Ignore Patient Safety in Recent Decision on Sarepta’s Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
STATEMENT RELEASE: Doctors for America’s FDA Task Force: the FDA Failed to Prioritize Patient Safety by Granting Lecanemab Accelerated Approval